Morgan Stanley’s latest EUR/USD forecast highlights the upside risk to the EUR/USD prices despite being neutral on the regional currency Euro (EUR).
Among the positive catalysts mentioned in the piece are, “more countries announce their economic reopening plans for the summer and Europe’s COVID vaccination rates continue to pick up.”
On the contrary, expectations of a delay in the European recovery fund weigh the EUR/USD prices, per the bank as it said, “The latest German Constitutional Court ruling removed a key obstacle to the launch of the EU recovery fund, but our economists think the first disbursement from the fund will likely still slip from 3Q to 4Q21.”
Read: EUR/USD Price Analysis: Keeps bounce off 100-day SMA on Fed day
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.
